Literature DB >> 26882884

Stem cells: HSCT for Crohn's disease: work in progress or a bridge too far?

Daniel W Hommes1, Precious N Lacey1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26882884     DOI： 10.1038/nrgastro.2016.22

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up.

Authors:  Richard K Burt; Robert M Craig; Francesca Milanetti; Kathleen Quigley; Paula Gozdziak; Jurate Bucha; Alessandro Testori; Amy Halverson; Larissa Verda; Willem J S de Villiers; Borko Jovanovic; Yu Oyama
Journal:  Blood       Date:  2010-09-13       Impact factor: 22.113

2.  Risks of immune system treatments.

Authors:  Richard K Burt; Mario Abinun; Dominique Farge-Bancel; Athanasios Fassas; Falk Hiepe; Eva Havrdová; Susumu Ikehara; Yvonne Loh; Alberto Marmont du Haut Champ; Júlio C Voltarelli; John Snowden; Shimon Slavin
Journal:  Science       Date:  2010-05-14       Impact factor: 47.728

3.  Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.

Authors:  F L Wolters; M G Russel; J Sijbrandij; L J Schouten; S Odes; L Riis; P Munkholm; P Bodini; C O'Morain; I A Mouzas; E Tsianos; S Vermeire; E Monteiro; C Limonard; M Vatn; G Fornaciari; S Pereira; B Moum; R W Stockbrügger
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

4.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

Authors:  Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van De Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad A van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

5.  Stem cells as potential novel therapeutic strategy for inflammatory bowel disease.

Authors:  M Duijvestein; G R van den Brink; D W Hommes
Journal:  J Crohns Colitis       Date:  2008-02-20       Impact factor: 9.071

6.  Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

Authors:  Gary R Lichtenstein; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Robert H Diamond; Donny M Chen; Michelle L Pritchard; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05       Impact factor: 11.382

7.  Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Authors:  Dominique Farge; Myriam Labopin; Alan Tyndall; Athanasios Fassas; Gian Luigi Mancardi; Jaap Van Laar; Jian Ouyang; Tomas Kozak; John Moore; Ina Kötter; Virginie Chesnel; Alberto Marmont; Alois Gratwohl; Riccardo Saccardi
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

8.  Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Richard K Burt; Syamal K Datta
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

9.  Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

Authors:  Paolo A Muraro; Daniel C Douek; Amy Packer; Katherine Chung; Francisco J Guenaga; Riccardo Cassiani-Ingoni; Catherine Campbell; Sarfraz Memon; James W Nagle; Frances T Hakim; Ronald E Gress; Henry F McFarland; Richard K Burt; Roland Martin
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

10.  Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.

Authors:  Christopher J Hawkey; Matthieu Allez; Miranda M Clark; Myriam Labopin; James O Lindsay; Elena Ricart; Gerhard Rogler; Montserrat Rovira; Jack Satsangi; Silvio Danese; Nigel Russell; John Gribben; Peter Johnson; Jerome Larghero; Catherine Thieblemont; Sandro Ardizzone; Daan Dierickx; Adalberto Ibatici; Timothy Littlewood; Francesco Onida; Urs Schanz; Severine Vermeire; Jean-Frederic Colombel; Jean-Paul Jouet; Elizabeth Clark; Riccardo Saccardi; Alan Tyndall; Simon Travis; Dominique Farge
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272
  10 in total
  3 in total

Review 1.  Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.

Authors:  Natalie E Duran; Daniel W Hommes
Journal:  Therap Adv Gastroenterol       Date:  2016-04-25       Impact factor: 4.409

Review 2.  Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: A systematic review and meta-analysis.

Authors:  Xiao Qiu; Jue-Rong Feng; Li-Ping Chen; Shi Liu; Meng Zhang; Zhou Zhou; Jing Liu; Qiu Zhao
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn's disease.

Authors:  Milton Artur Ruiz; Roberto Luiz Kaiser; Luiz Gustavo de Quadros; Lilian Piron-Ruiz; Tatiana Peña-Arciniegas; Mikaell Alexandre Gouvea Faria; Rubens Camargo Siqueira; Flavio Fontes Pirozzi; Fernanda Soubhia Liedtke Kaiser; Richard K Burt
Journal:  BMC Res Notes       Date:  2017-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.